v3.26.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total revenue $ 2,175,485 $ 1,863,654 $ 4,190,710 $ 3,500,839
Operating expenses:        
Cost of services 1,352,665 1,090,540 2,634,912 2,131,485
Cost of goods sold 60,147 3,063 65,299 7,047
Selling, general, and administrative expenses 1,906,750 2,193,049 4,082,849 3,750,371
Impairment loss 1,397,353 1,397,353
Depreciation and amortization 145,573 169,737 288,271 404,199
Total operating expenses 3,465,135 4,853,742 7,071,331 7,690,455
Loss from operations (1,289,650) (2,990,088) (2,880,621) (4,189,616)
Other income (expense):        
Gain (loss) from equity method joint ventures (7,154) (19,911) 15,014 (4,815)
Gain on remeasurement 2,452,032 2,452,032
Gain (loss) on change in fair value of warrant liability 1,660,160 (3,790,225) 1,660,160
Loss on debt extinguishment (172,621) (692,270) (172,621) (692,270)
Gain on settlement 939,500 939,500
Interest income 139,514 139,514
Interest expense (177,227) (440,596) (357,550) (748,435)
Total other income (expense) 2,234,544 1,446,883 (1,713,836) 1,154,140
Net income (loss) from continuing operations before income taxes 944,894 (1,543,205) (4,594,457) (3,035,476)
Provision for income taxes 56,154 56,154
Net income (loss) from continuing operations before income taxes 888,740 (1,543,205) (4,650,611) (3,035,476)
Discontinued operations (Note 6)        
Loss on disposal of NTI (1,534,517) (1,534,517)
Loss on discontinued operations of NTI (541,247) (16,452,562)
Net income (loss) $ 888,740 $ (3,618,969) $ (4,650,611) $ (21,022,555)
Income (loss) from continuing operations per share        
Basic $ 0.42 $ (155.31) $ (2.48) $ (405.93)
Diluted 0.35 (155.31) (2.48) (405.93)
Loss from discontinued operations per common share        
Basic (208.91) (2,405.38)
Diluted (208.91) (2,405.38)
Income (loss) per common share:        
Basic 0.42 (364.23) (2.48) (2,811.31)
Diluted $ 0.35 $ (364.23) $ (2.48) $ (2,811.31)
Weighted average number of common shares outstanding:        
Basic 2,105,595 9,936 1,873,019 7,478
Diluted 2,592,025 9,936 1,873,019 7,478
Clinic Revenue [Member]        
Revenue:        
Total revenue $ 2,167,785 $ 1,832,094 $ 4,150,018 $ 3,453,647
Product [Member]        
Revenue:        
Total revenue $ 7,700 $ 31,560 $ 40,692 $ 47,192